Search for: "JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT"
Results 81 - 100
of 211
Sorted by Relevance
|
Sort by Date
29 Mar 2013, 12:25 am
Not likely, said Johnson. [read post]
29 Nov 2023, 5:00 am
Viagra: The Pharmaceutical Circle of Life In the 1990s, Pfizer was struggling to develop one of their compounds, sildenafil, for high blood pressure. [read post]
9 Apr 2008, 6:41 pm
The company began development of the product in 1996. [read post]
1 Mar 2015, 10:51 am
Xarelto (rivaroxoaban) was developed by Bayer and Janssen Pharmaceuticals in 2011, a new generation anticoagulant touted as a superior alternative to Coumadin. [read post]
21 Sep 2010, 12:42 am
TRADEMARK NOTICE: “Levaquin” is a trademark of Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., and Johnson & Johnson Pharmaceutical Research & Development. [read post]
5 Feb 2015, 10:21 am
Pharmaceutical companies filing infringement actions under 271(e)(2) wouldn’t need to comply. [read post]
24 Dec 2015, 6:43 am
Xarelto was developed and sold jointly by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary and Bayer Healthcare. [read post]
28 Nov 2009, 4:23 pm
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. [read post]
14 Mar 2012, 1:36 pm
Metal-on-Metal Implants Raise Safety Concerns Metal hip joints have been under scrutiny since Johnson & Johnson's DePuy unit recalled their ASR hip replacement systems due to high failure rates last year. [read post]
13 Feb 2018, 2:44 am
[viii] Abbott Laboratories – Founded in 1888, Abbott is based in Chicago, IL and develops and manufactures medical devices, pharmaceutical and healthcare products. [read post]
30 Aug 2007, 11:55 pm
Weight gain typically associated with the drug also contributes to the development of type 2 diabetes. [read post]
3 May 2007, 3:02 pm
And, it’s not just patents that are of a concern, many people die each year due to the lack of drug research and development into “non-profitable” infectious diseases such as tuberculosis and malaria. [read post]
24 Oct 2019, 8:00 am
Robert Levy, director of clinical development for Primus Pharmaceuticals, “Limbrel is, by far, the safest anti-inflammatory on the market. [read post]
2 Jul 2010, 1:25 pm
Leibowitz has frequently said that stopping pay-for-delay patent settlements in the pharmaceutical industry is one of the Commission’s highest antitrust priorities.Industry ResponseThe Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading pharmaceutical research and biotechnology companies, has come out against the legislation. [read post]
24 Oct 2012, 3:51 pm
KV further states that it employs personnel in the United States in positions ranging from specialized technical research and development staff to marketing and administrative staff. [read post]
12 Jun 2017, 1:00 am
The speakers were an interesting mix of academics, practitioners and industry representatives from both sides of the Atlantic, including Dominik Schnichels (European Commission, DG SANTE, Head of Unit Medical Products), Prof Murat Mungan (Antonin Scalia School of Law at George Mason University ), Prof Andreas Heinemann (U of Zurich), Angela Staunton (Vice President, Bayer AG), Prof Claudia Seitz (U of Basle), Alesch Staehelin (Research Counsel Europe, IBM), Simon Hirsbrunner (Steptoe… [read post]
29 Aug 2016, 1:19 pm
Both drugs are manufactured by Janssen Pharmaceutical, a subsidiary of the parent corporation Johnson & Johnson. [read post]
30 Jun 2016, 12:12 pm
Hunt, MD, FRCP, FRCPath, professor of thrombosis and hemostasis and director of the hemostasis research unit at Guy’s & St. [read post]
18 May 2011, 7:10 pm
According to the complaint, one such pharmaceutical distributor is LifeScan, Inc., a Johnson & Johnson Company. [read post]
26 Aug 2012, 8:42 pm
” The pharmaceutical maker said it will continue with its clinical trials. [read post]
